Cerence Q4 Adj EPS $0.09 Misses $0.15 Estimate, Sales $80.76M Beat $73.38M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cerence Inc. (CRNC) reported a significant decline in its Q4 financial results, with adjusted earnings per share (EPS) dropping to $(0.14) from $0.09 year-over-year (YoY), and sales falling to $58.14 million from $80.76 million YoY, representing a 255.56% decrease in EPS and a 28.01% decrease in sales.
November 27, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cerence Inc. experienced a substantial decrease in both EPS and sales in Q4, indicating a challenging period for the company compared to last year.
The reported decrease in both EPS and sales is a strong negative signal for investors, likely leading to a bearish outlook on the stock in the short term. The substantial decline in financial performance YoY is critical for investor sentiment and could result in a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100